5221 - 5230 of 8808 Results
Title
Year
-
OPENTitle: 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromesJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-019-0470-7Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-019-0470-7Citation Count: 149
-
OPENTitle: Mitochondrial Stasis Reveals p62-Mediated Ubiquitination in Parkin-Independent Mitophagy and Mitigates Nonalcoholic Fatty Liver DiseaseJournal Name: Cell MetabolismPublisher: Elsevier BVVol: 28Issue #: 4Start Page: 588End Page: 604.e5Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cmet.2018.06.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6170673Citation Count: 241
- Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease2022OPENTitle: Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01388-7Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-022-01388-7Citation Count: 77
-
OPENTitle: Toward the quantification of α-synuclein aggregates with digital seed amplification assaysJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 121Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2312031121Best OA location URL: https://doi.org/10.1073/pnas.2312031121Citation Count: 14
-
OPENTitle: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLBJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 115Issue #: 51Start Page: E12053End Page: E12062Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1813365115Best OA location URL: https://www.pnas.org/content/pnas/115/51/E12053.full.pdfCitation Count: 83
-
OPENTitle: NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug‐inducible neuroprotection from oxidative stressJournal Name: The FASEB JournalPublisher: WileyVol: 33Issue #: 10Start Page: 11223End Page: 11234Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1096/fj.201900830rBest OA location URL: https://doi.org/10.1096/fj.201900830rCitation Count: 90
-
OPENTitle: Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s diseaseJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-017-0935-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-017-0935-1Citation Count: 82
-
OPENTitle: Retrospective motion artifact correction of structural MRI images using deep learning improves the quality of cortical surface reconstructionsJournal Name: NeuroImagePublisher: Elsevier BVVol: 230Issue #:Start Page: 117756End Page: 117756Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuroimage.2021.117756Best OA location URL: https://doi.org/10.1016/j.neuroimage.2021.117756Citation Count: 77
-
RESTRICTEDTitle: Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 9Issue #: 12Start Page: 1164End Page: 1172Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(10)70254-4Citation Count: 655
-
OPENTitle: Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 136End Page: 148Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.004Best OA location URL: https://repositorio.uchile.cl/handle/2250/167345Citation Count: 145